B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

FPR1

MOLECULAR TARGET

formyl peptide receptor 1

UniProt: P21462NCBI Gene: 23576 compounds

FPR1 (formyl peptide receptor 1) is targeted by 6 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting FPR1

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1Phenylbutazone1.614
2Sulfinpyrazone1.614
3Chenodeoxycholic Acid0.691
4Deoxycholic Acid0.691
5Monoiodotyrosine0.691
6Perphenazine0.691

About FPR1 as a Drug Target

FPR1 (formyl peptide receptor 1) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 6 compounds with documented FPR1 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

FPR1 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.